Pārskats
Akcijas cenas izmaiņa
24h
Šī brīža
Min
0.61
Max
0.96
Ienākumi | 14M -6M |
|---|---|
Darbinieki | 112 |
EBITDA | 3.3M -18M |
Rekomendācijas | Pirkt |
|---|---|
Prognoze 12 mēnešiem | +241.24% upside |
Nākamie ieņēmumi | 2026. g. 9. nov. |
|---|
Tirgus kapitalizācija | -24M 80M |
|---|---|
Iepriekšējā atvēršanas cena | 18.15 |
Iepriekšējā slēgšanas cena | 0.76 |
Inovio Pharmaceuticals Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Saistītās ziņas
2026. g. 29. okt. 23:56 UTC
Jack Henry & Associates reported $17.9 million in deconversion revenue for Q1 2026 and projected $30 million for fiscal 2027.
Lasīt
2026. g. 29. okt. 23:56 UTC
Citigroup maintains Buy rating on Sherwin-Williams, lowering price target to $370; RBC Capital reaffirms Outperform rating, adjusting target to $383.
Lasīt
2026. g. 29. okt. 23:56 UTC
Duolingo faces multiple class action lawsuits alleging securities law violations related to false statements on user growth and AI content quality.
Lasīt
2026. g. 29. okt. 23:51 UTC
Argus Research downgraded Wendy's Co to Sell, citing concerns over growth prospects and competitive pressures in the fast-food sector.
Lasīt
2026. g. 29. okt. 23:51 UTC
Citigroup maintains Neutral rating on Rexford Industrial Realty, lowering its price target to $40 in a report published after market hours.
Lasīt
2026. g. 29. okt. 23:51 UTC
MGM Resorts' shares declined after Macquarie lowered its price target to $46 and JP Morgan reduced its target to $39 following market close.
Lasīt
2026. g. 29. okt. 23:51 UTC
The European Central Bank held interest rates steady at 2.65% in October, aligning with market expectations amid rising inflation concerns.
Lasīt
2026. g. 29. okt. 23:46 UTC
JP Morgan maintains Overweight rating on C.H. Robinson Worldwide but lowers price target to $174, contributing to a modest decline in after-market trading.
Lasīt
2026. g. 29. okt. 23:46 UTC
Tenable Holdings, Inc. shares advanced in after-market trading as JP Morgan raised its price target to $41 and Canaccord Genuity increased its target to $54.
Lasīt
2026. g. 29. okt. 23:41 UTC
RBC Capital raised its price target on Prosperity Bancshares to $79, maintaining a Sector Perform rating in a report published after the market closed.
Lasīt
2026. g. 29. okt. 23:41 UTC
Olin Corporation reports Q3 net income of $14.4 million and projects Q4 adjusted EBITDA of $80 million to $100 million, citing customer destocking.
Lasīt
2026. g. 29. okt. 23:41 UTC
Prospect Capital Corporation prices a $300 million offering of 8.95% unsecured notes due in 2031, aimed at refinancing debt and general corporate purposes.
Lasīt
2026. g. 29. okt. 23:36 UTC
The Nikkei 225 Index declined in after-market hours following a drop in Japan's consumer confidence index to 35.0 and Toyota's production cuts in China.
Lasīt
2026. g. 29. okt. 23:31 UTC
The euro is gaining against the Norwegian krone as the ECB holds rates steady and warns of rising inflation risks, ending a six-day decline.
Lasīt
2026. g. 29. okt. 23:31 UTC
Lennar Corporation filed with the SEC to amend its revolving credit agreement, increasing commitments to $3.80 billion and borrowing capacity to $4.55 billion.
Lasīt
2026. g. 29. okt. 23:26 UTC
Macquarie maintains Neutral rating on Hilton Worldwide and raises price target to $333, reflecting a positive assessment of the company's performance and market position.
Lasīt
2026. g. 29. okt. 23:21 UTC
JP Morgan maintains Overweight rating on International Paper, lowering price target to $51, reflecting confidence amid a rise in the Paper & Plastic Packaging sector.
Lasīt
2026. g. 29. okt. 23:16 UTC
Exelixis reports Q3 2026 revenues of $658.7 million and GAAP net income of $218.1 million, exceeding analyst expectations, while shares declined in after-market trading.
Lasīt
2026. g. 29. okt. 23:16 UTC
PG&E Corp shares rose in after-market hours, supported by mixed options sentiment with a put/call ratio of 0.16 and decreased implied volatility at 41.1.
Lasīt
2026. g. 29. okt. 23:16 UTC
Brown & Brown Inc recognized as a Certified™ Great Place to Work® for the eighth year and included in Fortune's 2026 Best Workplaces lists.
Lasīt
2026. g. 29. okt. 23:12 UTC
SkyWest, Inc. reported Q3 2026 net income of $119.5 million, or $3.08 per share, with revenue of $1.12 billion, missing analyst expectations.
Lasīt
2026. g. 29. okt. 23:11 UTC
New Fortress Energy Inc. leases ten mobile turbines for up to 300 megawatts to a U.S. investment-grade company, enhancing earnings and liquidity.
Lasīt
2026. g. 29. okt. 23:11 UTC
Cherry Hill Mortgage Investment Corporation reported Q3 adjusted EPS of $0.14, revenues of $6.558 million, and a net loss of $1.5 million.
Lasīt
2026. g. 29. okt. 23:11 UTC
Ethereum is trading lower, reflecting a significant decline since Wednesday's close, amid cautious investor sentiment following the Fed's rate decision and falling crude oil prices.
Lasīt
2026. g. 29. okt. 23:06 UTC
Textron Inc reported Q3 revenue of $3.75 billion and raised 2026 GAAP EPS guidance to $5.64-$5.74, with shares advancing in after-market trading.
Lasīt
2026. g. 29. okt. 23:06 UTC
JP Morgan maintains Neutral rating on Centene Corp and raises price target to $75 in a report published today.
Lasīt
2026. g. 29. okt. 23:06 UTC
Biogen Inc. receives an upgrade to Buy from Argus Research with a price target of $280, while Canaccord Genuity raises its target to $272.
Lasīt
2026. g. 29. okt. 23:06 UTC
Ethereum is trading lower, continuing its decline as cautious investor sentiment grows following the Federal Reserve's rate decision and mixed economic signals.
Lasīt
2026. g. 29. okt. 23:06 UTC
Bitcoin faces downward pressure amid reports of a potential $2 billion hack linked to Binance, contributing to negative market sentiment and testing local range lows.
Lasīt
2026. g. 29. okt. 23:06 UTC
Bitcoin is under downward pressure amid reports of a potential $2 billion hack linked to Binance, testing local range lows as negative sentiment persists.
Lasīt
Salīdzinājums
Cenas izmaiņa
Inovio Pharmaceuticals Inc Prognoze
Cenas mērķis
By TipRanks
Prognoze 12 mēnešiem
Vidējais 3.167 USD 241.24%
Augstākais 4 USD
Zemākais 2.5 USD
Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Inovio Pharmaceuticals Inc — pēdējo 3 mēnešu laikā.
Vērtējuma vienprātība
By TipRanks
Pirkt
3 ratings
2
Pirkt
1
Turēt
0
Pārdot
Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Inovio Pharmaceuticals Inc — pēdējo 3 mēnešu laikā.
Finanšu rādītāji
Pārdošanas un administrēšanas izmaksas
Peļņa pirms nodokļu nomaksas
Pārdošana
Procentu izdevumi par parādu
EBITDA
Pamatdarbības peļņa
$